Document is current
Any future updates will be listed below
-
Authors
Götze, Thorsten Oliver
Waidmann, Oliver
Oldhafer, Karl J.
Vogel, Arndt
- License Information
-
More Information
Article History
Accepted: 18 January 2022
First Online: 25 January 2022
Einhaltung ethischer Richtlinien
:
: T.O. Götze has an advisory role with Lilly, MSD Sharp & Dohme, Ipsen, Bayer, Celgene, Servier, Roche and is a speaker for Lilly, MCI, MSD Sharp & Dohme, Servier. He has received research grants from German Research Foundation (DFG), Gemeinsamer Bundesausschuss, Deutsche Krebshilfe, Lilly, Incyte and Astra Zeneca. O. Waidmann is a speaker, consultant or advisor for Amgen, AstraZeneca, Bayer, BMS, Celgene, Eisai, Incyte, Ipsen, Merck Serono, MSD, Novartis, Roche, Servier and Shire. He has received research grants from Else Kröner-Fresenius-Stiftung, Ipsen, and Medac. A. Vogel is a speaker, consultant or advisor for Amgen, Roche, Bayer, Sanofi, BMS, Lilly, Novartis, EISAI, AstraZeneca, Merck, Incyte, Ipsen, Pierre Fabre, MSD, Sirtex, BTG, Servier, Terumo, GSK. K.J. Oldhafer declares that he has no competing interests.
: Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.
